T
TubeFolio
Back to Dashboard

Is Boeing an Undervalued Dividend Stock to Buy Right Now? | BA Stock Analysis

Parkev Tatevosian, CFA•Nov 14, 2026

Summary

Parkev examines Boeing's current market position following a 20% decline in stock price during early 2026. Parkev highlights that while Boeing possesses a massive backlog worth hundreds of billions of dollars, the company's primary struggle is execution. Parkev notes that management has repeatedly pushed back targets for increasing production to 52 aircraft per month, with the current estimate now set for the second half of 2027. Parkev expresses skepticism about these targets given Boeing's history of missing delivery estimates.

From a financial standpoint, Parkev observes that Boeing's revenue is recovering toward pre-2020 levels but profitability remains constrained. Parkev explains that because Boeing is a major government contractor, achieving high profit margins is difficult due to regulatory and public scrutiny. Parkev acknowledges that Boeing has successfully reduced its long-term debt from $65 billion to $41 billion and holds over $20 billion in cash, but remains cautious about the stock's valuation. Parkev points out that a forward price-to-earnings ratio of 80 is expensive for a company with limited growth and margin potential.

BA: Parkev rates Boeing as a HOLD and maintains a neutral stance on the stock. Parkev calculates a fair value of $165 per share using a discounted cash flow model, suggesting the current market price of $173 does not offer a sufficient margin of safety. Parkev argues that until Boeing can consistently meet its production ramp-up goals and improve its volatile earnings per share, it does not represent an attractive buying opportunity.

Mentioned Stocks

BA
Sentiment: HOLDAction: RECOMMENDED

Reasoning: Parkev calculates a fair value of $165 per share for Boeing using a discounted cash flow model, while the stock currently trades around $173. Parkev argues that the forward P/E ratio of 80 is too expensive given the company's execution risks and delayed production targets. While Parkev likes the large order backlog, the ongoing struggle to ramp up production to 52 planes per month makes Parkev cautious about recommending a buy at this time.

Loading chart...